Hemagen Diagnostics (Hemagen Diagnostics) Change In Receivables : $-0.01 Mil (TTM As of Sep. 2012)

View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics Change In Receivables?

Hemagen Diagnostics's change in receivables for the quarter that ended in Sep. 2012 was $-0.00 Mil. It means Hemagen Diagnostics's Accounts Receivable increased by $0.00 Mil from Jun. 2012 to Sep. 2012 .

Hemagen Diagnostics's change in receivables for the fiscal year that ended in Sep. 2012 was $-0.01 Mil. It means Hemagen Diagnostics's Accounts Receivable increased by $0.01 Mil from Sep. 2011 to Sep. 2012 .

Hemagen Diagnostics's Accounts Receivable for the quarter that ended in Sep. 2012 was $0.59 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Hemagen Diagnostics's Days Sales Outstanding for the three months ended in Sep. 2012 was 61.25.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Hemagen Diagnostics's liquidation value for the three months ended in Sep. 2012 was $-4.81 Mil.

Hemagen Diagnostics Change In Receivables Historical Data

The historical data trend for Hemagen Diagnostics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics Change In Receivables Chart

Hemagen Diagnostics Annual Data

Trend

Sep03

Sep04

Sep05

Sep06

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Change In Receivables

Get a 7-Day Free Trial

0.12

0.20

-0.03

0.08

-0.01

Hemagen Diagnostics Quarterly Data
	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12
Change In Receivables	Get a 7-Day Free Trial															0.05	0.16	-0.16	-	-

Hemagen Diagnostics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.

Hemagen Diagnostics (OTCPK:HMGN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hemagen Diagnostics's Days Sales Outstanding for the quarter that ended in Sep. 2012 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.588	/	0.876	*	91
=	61.25

2. In Ben Graham's calculation of liquidation value, Hemagen Diagnostics's accounts receivable are only considered to be worth 75% of book value:

Hemagen Diagnostics's liquidation value for the quarter that ended in Sep. 2012 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.066	-	6	+	0.75 * 0.588	+	0.5 * 1.363
=	-4.81

Hemagen Diagnostics Change In Receivables Related Terms

Thank you for viewing the detailed overview of Hemagen Diagnostics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

9033 Red Branch Road, Columbia, MD, USA, 21045

Website

http://www.hemagen.com

Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.

Executives

Howard F Curd

director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines